Kailera Therapeutics, Inc. (KLRA)

15.40 -0.81 (-5.00%) USD  |  NASDAQ  |  Aug 31, 16:00
15.38 -0.02 (-0.10%) After-Hours: 20:00
More

Kailera Therapeutics Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Free Cash Flow Per Share (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --
Date Value
March 31, 2026 --

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Sana Biotechnology, Inc. Upgrade
Parabilis Medicines, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow to Firm (Quarterly) Upgrade